Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506-Reference-Cited by-同舟云学术

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506

Published:2021-10-08 Issue:12 Volume:20 Page:2372-2383
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

van der Wiel Alexander M.A.^ORCID,Jackson-Patel Victoria^ORCID,Niemans Raymon,Yaromina Ala,Liu Emily,Marcus Damiënne,Mowday Alexandra M.^ORCID,Lieuwes Natasja G.,Biemans Rianne,Lin Xiaojing^ORCID,Fu Zhe^ORCID,Kumara Sisira,Jochems Arthur,Ashoorzadeh Amir^ORCID,Anderson Robert F.,Hicks Kevin O.^ORCID,Bull Matthew R.,Abbattista Maria R.,Guise Christopher P.,Deschoemaeker Sofie^ORCID,Thiolloy Sophie,Heyerick Arne,Solivio Morwena J.,Balbo Silvia,Smaill Jeff B.^ORCID,Theys Jan,Dubois Ludwig J.^ORCID,Patterson Adam V.^ORCID,Lambin Philippe

Funder

Health Research Council of New Zealand

Walloon Region of Belgium

EUROSTARS grant COMPACT

Cancer Society Auckland Northland

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting hypoxic and acidic tumor microenvironment by nanoparticles: A review;Journal of Drug Delivery Science and Technology;2024-06

2. The Catalysis Mechanism of E. coli Nitroreductase A, a Candidate for Gene-Directed Prodrug Therapy: Potentiometric and Substrate Specificity Studies;International Journal of Molecular Sciences;2024-04-17

3. Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models;Molecular Oncology;2024-03

4. Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance;Clinical and Translational Radiation Oncology;2024-01

5. AGENTES ANTINEOPLÁSICOS BIORREDUTÍVEIS: AVANÇOS E DESAFIOS APÓS 20 ANOS;Química Nova;2024